Back to the Top
The following message was posted to: PharmPK
I would like to have advice about dissolution specifications established
with an IVIVC.
Can we simply evaluate a risk of being bioinequivalent with these
Is there any further correction to bring to these limits so that the
of being bioinequivalent in vivo is reduced?
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (firstname.lastname@example.org)